Theleme Partners LLP

Q3 2024 13F Holdings Report, Stock Holdings

Signature - Title
Lucy Elwes - Chief Compliance Officer
Location
London, United Kingdom
Holdings as of
September 30, 2024
Value $
$1.7B
Num holdings
10
Date filed
11/14/2024, 12:52 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, SCHW, TRU, EFX, and HRI.
Previous filing
Q2 2024 - Aug 14, 2024
Next filing
Q4 2024 - Feb 14, 2025
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q3 compared to 2024 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Lucy Elwes Chief Compliance Officer London, United Kingdom 11/14/2024

Other Included Managers (2):

Num Name Location File Number
1 Theleme Master Fund Ltd Dublin, Ireland 028-14311
2 Theleme Special Purpose Fund I LP Dublin 1, Ireland 028-22495